• Explore /
  • Poster
  • / Efficacy of sorafenib in patients with oligometastatic hepatoceulluar carcinoma (HCC).

Efficacy of sorafenib in patients with oligometastatic hepatoceulluar carcinoma (HCC).

Abstract Poster

Authors

null

Kiruthikah Thillai

Department of Oncology, King's College Hospital, London, United Kingdom

Kiruthikah Thillai , Dimitrios Ziogas , Ippokratis Korantzis , MH Ruhe Chowdhury , Dionysios Papadatos-Pastos , Abid Suddle , John O'Grady , Nigel Heaton , Paul J. Ross , Debashis Sarker

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 33, 2015 (suppl 3; abstr 389)

DOI

10.1200/jco.2015.33.3_suppl.389

Abstract #

389

Poster Bd #

D8

Abstract Disclosures

Similar Posters

Poster

2014 Gastrointestinal Cancers Symposium

A multicenter phase II study of sorafenib in Japanese patients with hepatocellular carcinoma and Child Pugh A or B cirrhosis.

A multicenter phase II study of sorafenib in Japanese patients with hepatocellular carcinoma and Child Pugh A or B cirrhosis.

First Author: Eiichiro Suzuki

First Author: Spyridon Pantzios

First Author: William Joseph Chapin

First Author: Amit G. Singal